Marshall Wace LLP Makes New $14.81 Million Investment in Tempus AI, Inc. (NASDAQ:TEM)

Marshall Wace LLP purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 438,806 shares of the company’s stock, valued at approximately $14,814,000. Marshall Wace LLP owned approximately 0.28% of Tempus AI at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the stock. ARK Investment Management LLC increased its stake in Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after acquiring an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. increased its position in shares of Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. Franklin Resources Inc. raised its stake in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after purchasing an additional 1,950,862 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Tempus AI by 86,947.2% during the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after purchasing an additional 1,651,996 shares during the period. 24.22% of the stock is currently owned by institutional investors.

Insider Activity

In other Tempus AI news, EVP Andrew Polovin sold 13,135 shares of Tempus AI stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total transaction of $603,947.30. Following the transaction, the executive vice president now directly owns 154,171 shares of the company’s stock, valued at approximately $7,088,782.58. The trade was a 7.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erik Phelps sold 5,934 shares of the stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total value of $400,960.38. Following the completion of the sale, the executive vice president now directly owns 214,662 shares of the company’s stock, valued at approximately $14,504,711.34. The trade was a 2.69 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,146,249 shares of company stock valued at $301,185,058 over the last quarter.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on TEM shares. Bank of America raised their target price on shares of Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. JPMorgan Chase & Co. downgraded shares of Tempus AI from an “overweight” rating to a “neutral” rating and boosted their price objective for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Piper Sandler cut their target price on Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. TD Cowen reiterated a “buy” rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Finally, Loop Capital dropped their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Price Performance

Tempus AI stock opened at $40.42 on Monday. The stock has a 50-day moving average price of $53.49 and a two-hundred day moving average price of $50.52. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.